Q TECH (01478) completed the subscription of 20 million shares of New Giant Technology for a placement of shares.
Qiu Titanium Technology (01478) announced that the company's participation in the private placement of New Jute Technology has been completed on March 3, 2025.
Q TECH (01478) announced that the company's participation in the private placement of New Giant Technology was completed on March 3, 2025. A total of 20 million shares of the private placement shares were issued to the company at a price of NT$22.16 per share, equivalent to approximately 9.8% of the total number of issued ordinary shares of New Giant Technology after the private placement was completed.
After the above-mentioned private placement was completed, the company directly and indirectly holds a total of 85,330,589 shares of New Giant Technology's ordinary shares, equivalent to approximately 41.8% of the total number of issued ordinary shares of New Giant Technology after the private placement was completed.
The announcement stated that the company will continue to work to enhance New Giant Technology's lens capabilities in areas such as smartphones, AR/VR, and IoT. The directors believe that participating in the private placement will help the group form a better vertical chain integration and further develop towards becoming a smart visual system solution provider, in line with the overall interests of the company and its shareholders. Therefore, despite the impact of the fluctuation in New Giant Technology's share price after the signing of the subscription agreement, leading to a final placement price approximately 5.5% higher than the provisional placement price, the board of directors has agreed to subscribe for the placement shares at the final placement price.
Related Articles

HK Stock Market Move | YUNJI Technology (02670) rose more than 7% in morning trading and reached a strategic cooperation with SF INTRA-CITY to promote the large-scale implementation of intelligent building services.

HK Stock Market Move | IMMUNEONCO-B(01541) up by more than 10%, IMM0306 approved for Phase II clinical trial in the treatment of primary membranous nephropathy

HK Stock Market Move | GDS-SW(09698) rose over 12% last year, with adjusted EBITDA increasing by 10% year-on-year. Operating data performance was strong.
HK Stock Market Move | YUNJI Technology (02670) rose more than 7% in morning trading and reached a strategic cooperation with SF INTRA-CITY to promote the large-scale implementation of intelligent building services.

HK Stock Market Move | IMMUNEONCO-B(01541) up by more than 10%, IMM0306 approved for Phase II clinical trial in the treatment of primary membranous nephropathy

HK Stock Market Move | GDS-SW(09698) rose over 12% last year, with adjusted EBITDA increasing by 10% year-on-year. Operating data performance was strong.

RECOMMEND

European Carmakers Embrace China: Under Technology And Cost Pressure, Stellantis And Mercedes Seek Partnerships With Chinese Automakers
17/03/2026

HKEX Listing Mechanism Reform Revisited: How To Balance New Favorites And Established Names
17/03/2026

International Oil Prices Plunge Boosts U.S. Stocks; Morgan Stanley Chief Says Market Correction Nearing End
17/03/2026


